DeepMed Research

Nanfang Hospital Southern Medical University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

SD vs. NSD Therapy in Elderly AML

Conditions: Non-standard Therapy
Standard Therapy

First Posted Date: 2018-11-07

Last Posted Date: 2018-11-07

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 1000

Registration Number: NCT03733834

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT

Phase 2

Conditions: Conditioning
Primary Central Nervous System Lymphoma
Autologous Hematopoietic Stem Cell Transplantation

Interventions: Drug: Busulfan (BU)
Drug: Cyclophosphamide (CY)
Drug: Etoposide (VP-16)

First Posted Date: 2018-11-07

Last Posted Date: 2018-11-07

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 20

Registration Number: NCT03733327

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Text Messaging and Cardiovascular Health in Diabetes Mellitus

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Behavioral: Text messaging

First Posted Date: 2018-10-30

Last Posted Date: 2022-10-24

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 819

Registration Number: NCT03724526

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

Dapagliflozin Efficacy and Action in NASH

Phase 3

Completed

Conditions: Nonalcoholic Steatohepatitis

Interventions: Drug: Dapagliflozin
Drug: Placebo

First Posted Date: 2018-10-29

Last Posted Date: 2024-03-29

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 154

Registration Number: NCT03723252

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

Measurement of the Distance Between the Corresponding Anatomical Landmarks in the Thoracic Cavity and the Incisors

Conditions: Pulmonary Resection

First Posted Date: 2018-10-25

Last Posted Date: 2018-10-25

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 520

Registration Number: NCT03720405

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guandong, Guangdong, China

Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802)

Conditions: Hypertension, Portal

Interventions: Procedure: HVPG measurement

First Posted Date: 2018-10-22

Last Posted Date: 2021-08-17

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 75

Registration Number: NCT03713606

Locations: 🇨🇳
Shandong Provincial Hospital, Jinan, China
🇨🇳
Beijing Friendship Hospital, Beijing, China
🇨🇳
302 Hospital of PLA, Beijing, China

and more 3 locations

Platelet Transfusion in HBV-related acute-on Chronic Liver Failure

Not Applicable

Conditions: Acute-On-Chronic Liver Failure

Interventions: Procedure: platelet

First Posted Date: 2018-10-19

Last Posted Date: 2018-10-22

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 20

Registration Number: NCT03713489

Locations: 🇨🇳
Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Phase 2

Conditions: Acute Myeloid Leukemia
Eltrombopag
Thrombocytopenia

Interventions: Drug: Eltrombopag

First Posted Date: 2018-10-09

Last Posted Date: 2018-10-09

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 220

Registration Number: NCT03701217

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis

Conditions: Prospective Study
Ulcerative Colitis in Remission

Interventions: Combination Product: Colonoscope

First Posted Date: 2018-10-09

Last Posted Date: 2018-10-17

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 9

Registration Number: NCT03698812

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

Active, not recruiting

Conditions: Osteoporosis, Postmenopausal
Vertebral Fracture
Quality of Life

Interventions: Drug: Teriparatide
Procedure: PVP
Drug: Alendronate

First Posted Date: 2018-10-02

Last Posted Date: 2018-10-02

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 90

Registration Number: NCT03692143

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy